Isomorphic Labs Raises $2.1 Billion To Advance AI Drug Trials
Alphabet’s Isomorphic Labs has raised $2.1 billion in new funding to expand its artificial intelligence-driven drug discovery work and push more programs toward clinical trials, according to published reports. The financing was described as a Series B round totaling $2.1 billion. Isomorphic Labs is an Alphabet company focused on using AI models to help design…
